As of 2026, it was removed from the FDA's Category 2 restriction list and is under active review by the Pharmacy Compounding Advisory Committee, with a scheduled meeting on July 23, 2026, to evaluate its inclusion on the 503A Bulk Drug Substances List
Serious Side Effects (Rare) While uncommon, serious side effects require immediate medical attention: Acute pancreatitis (sudden pancreas inflammation) Severe dehydration from persistent vomiting/diarrhea Hypoglycemia (low blood sugar) when combined with insulin Acute gallbladder disease Long-Term Safety Studies of 72-week Mounjaro treatment at the highest dose (15mg) revealed no negative long-term side effects
C., Werner, S., Barrandon, Y., & Longaker, M
Lets explore them
Ma forse ti chiedi come funziona esattamente e perch un farmaco per il diabete dovrebbe essere efficace anche per dimagrire
We feel like we have priced appropriately for it, so we feel like the risk is manageable, CVS CEO Karen Lynch said, but in pharmacy services, it is generating very strong revenue. Does it impact insurance premiums vis-a-vis risk scores for ACA and MA plans if a population is generally less burdened by chronic disease
